vs
Side-by-side financial comparison of ADMA BIOLOGICS, INC. (ADMA) and Energy Services of America CORP (ESOA). Click either name above to swap in a different company.
ADMA BIOLOGICS, INC. is the larger business by last-quarter revenue ($139.2M vs $114.1M, roughly 1.2× Energy Services of America CORP). On growth, ADMA BIOLOGICS, INC. posted the faster year-over-year revenue change (18.4% vs 13.4%). ADMA BIOLOGICS, INC. produced more free cash flow last quarter ($34.6M vs $16.8M). Over the past eight quarters, ADMA BIOLOGICS, INC.'s revenue compounded faster (30.4% CAGR vs 26.7%).
ADMA Biologics Inc. is a biopharmaceutical enterprise focused on the research, development, manufacturing and commercialization of specialty plasma-derived immunoglobulin therapies. It primarily operates in the United States, catering to patients with primary immunodeficiency and other immune-related disorders, healthcare providers and medical institutions across its core immune health therapeutic segment.
Superior Energy Services is an American oil services company that operates as a holding company for a portfolio of oilfield equipment rentals and well oil and gas services brands.
ADMA vs ESOA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $139.2M | $114.1M |
| Net Profit | $49.4M | — |
| Gross Margin | 63.8% | 12.3% |
| Operating Margin | 45.1% | 4.3% |
| Net Margin | 35.5% | — |
| Revenue YoY | 18.4% | 13.4% |
| Net Profit YoY | -55.9% | — |
| EPS (diluted) | $0.20 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $139.2M | $114.1M | ||
| Q3 25 | $134.2M | $130.1M | ||
| Q2 25 | $122.0M | $103.6M | ||
| Q1 25 | $114.8M | $76.7M | ||
| Q4 24 | $117.5M | $100.6M | ||
| Q3 24 | $119.8M | $104.7M | ||
| Q2 24 | $107.2M | $85.9M | ||
| Q1 24 | $81.9M | $71.1M |
| Q4 25 | $49.4M | — | ||
| Q3 25 | $36.4M | — | ||
| Q2 25 | $34.2M | — | ||
| Q1 25 | $26.9M | — | ||
| Q4 24 | $111.9M | — | ||
| Q3 24 | $35.9M | — | ||
| Q2 24 | $32.1M | — | ||
| Q1 24 | $17.8M | — |
| Q4 25 | 63.8% | 12.3% | ||
| Q3 25 | 56.3% | 12.6% | ||
| Q2 25 | 55.1% | 11.6% | ||
| Q1 25 | 53.2% | 0.1% | ||
| Q4 24 | 53.9% | 10.2% | ||
| Q3 24 | 49.8% | 16.8% | ||
| Q2 24 | 53.6% | 17.8% | ||
| Q1 24 | 47.8% | 8.8% |
| Q4 25 | 45.1% | 4.3% | ||
| Q3 25 | 38.0% | 5.8% | ||
| Q2 25 | 35.1% | 3.1% | ||
| Q1 25 | 30.4% | -10.6% | ||
| Q4 24 | 32.6% | 1.6% | ||
| Q3 24 | 33.1% | 8.4% | ||
| Q2 24 | 36.6% | 9.9% | ||
| Q1 24 | 26.7% | -1.5% |
| Q4 25 | 35.5% | — | ||
| Q3 25 | 27.1% | — | ||
| Q2 25 | 28.1% | — | ||
| Q1 25 | 23.4% | — | ||
| Q4 24 | 95.2% | — | ||
| Q3 24 | 30.0% | — | ||
| Q2 24 | 29.9% | — | ||
| Q1 24 | 21.7% | — |
| Q4 25 | $0.20 | $0.16 | ||
| Q3 25 | $0.15 | $0.26 | ||
| Q2 25 | $0.14 | $0.12 | ||
| Q1 25 | $0.11 | $-0.41 | ||
| Q4 24 | $0.45 | $0.05 | ||
| Q3 24 | $0.15 | $0.40 | ||
| Q2 24 | $0.13 | $1.06 | ||
| Q1 24 | $0.08 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $87.6M | $16.7M |
| Total DebtLower is stronger | $72.1M | $62.0M |
| Stockholders' EquityBook value | $477.3M | $60.6M |
| Total Assets | $624.2M | $201.0M |
| Debt / EquityLower = less leverage | 0.15× | 1.02× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.6M | $16.7M | ||
| Q3 25 | $61.4M | $12.2M | ||
| Q2 25 | $90.3M | $15.3M | ||
| Q1 25 | $71.6M | $9.9M | ||
| Q4 24 | $103.1M | $20.3M | ||
| Q3 24 | $86.7M | $12.9M | ||
| Q2 24 | $88.2M | $14.5M | ||
| Q1 24 | $45.3M | $12.1M |
| Q4 25 | $72.1M | $62.0M | ||
| Q3 25 | $72.4M | $72.2M | ||
| Q2 25 | — | $59.1M | ||
| Q1 25 | — | $50.7M | ||
| Q4 24 | $72.3M | $59.6M | ||
| Q3 24 | — | $33.9M | ||
| Q2 24 | — | $31.9M | ||
| Q1 24 | — | $45.7M |
| Q4 25 | $477.3M | $60.6M | ||
| Q3 25 | $431.2M | $59.2M | ||
| Q2 25 | $398.3M | $54.4M | ||
| Q1 25 | $373.4M | $53.7M | ||
| Q4 24 | $349.0M | $61.0M | ||
| Q3 24 | $231.9M | $58.7M | ||
| Q2 24 | $188.3M | $52.0M | ||
| Q1 24 | $153.7M | $34.6M |
| Q4 25 | $624.2M | $201.0M | ||
| Q3 25 | $568.7M | $215.2M | ||
| Q2 25 | $558.4M | $189.1M | ||
| Q1 25 | $510.6M | $170.2M | ||
| Q4 24 | $488.7M | $192.1M | ||
| Q3 24 | $390.6M | $158.2M | ||
| Q2 24 | $376.4M | $148.8M | ||
| Q1 24 | $350.9M | $136.1M |
| Q4 25 | 0.15× | 1.02× | ||
| Q3 25 | 0.17× | 1.22× | ||
| Q2 25 | — | 1.09× | ||
| Q1 25 | — | 0.94× | ||
| Q4 24 | 0.21× | 0.98× | ||
| Q3 24 | — | 0.58× | ||
| Q2 24 | — | 0.61× | ||
| Q1 24 | — | 1.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $35.6M | $18.8M |
| Free Cash FlowOCF − Capex | $34.6M | $16.8M |
| FCF MarginFCF / Revenue | 24.8% | 14.7% |
| Capex IntensityCapex / Revenue | 0.8% | 1.8% |
| Cash ConversionOCF / Net Profit | 0.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | $27.8M | $3.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.6M | $18.8M | ||
| Q3 25 | $13.3M | $-9.3M | ||
| Q2 25 | $21.1M | $3.4M | ||
| Q1 25 | $-19.7M | $1.1M | ||
| Q4 24 | $50.2M | $8.9M | ||
| Q3 24 | $25.0M | $-847.5K | ||
| Q2 24 | $45.6M | $19.3M | ||
| Q1 24 | $-2.2M | $-2.7M |
| Q4 25 | $34.6M | $16.8M | ||
| Q3 25 | $-1.1M | $-12.0M | ||
| Q2 25 | $18.7M | $-582.0K | ||
| Q1 25 | $-24.4M | $-1.1M | ||
| Q4 24 | $47.5M | $6.0M | ||
| Q3 24 | $24.0M | $-2.9M | ||
| Q2 24 | $43.6M | $16.3M | ||
| Q1 24 | $-4.6M | $-4.9M |
| Q4 25 | 24.8% | 14.7% | ||
| Q3 25 | -0.8% | -9.3% | ||
| Q2 25 | 15.3% | -0.6% | ||
| Q1 25 | -21.2% | -1.4% | ||
| Q4 24 | 40.4% | 5.9% | ||
| Q3 24 | 20.0% | -2.8% | ||
| Q2 24 | 40.7% | 18.9% | ||
| Q1 24 | -5.6% | -6.9% |
| Q4 25 | 0.8% | 1.8% | ||
| Q3 25 | 10.7% | 2.1% | ||
| Q2 25 | 2.0% | 3.9% | ||
| Q1 25 | 4.1% | 2.9% | ||
| Q4 24 | 2.3% | 2.9% | ||
| Q3 24 | 0.9% | 2.0% | ||
| Q2 24 | 1.9% | 3.6% | ||
| Q1 24 | 2.9% | 3.1% |
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.62× | — | ||
| Q1 25 | -0.73× | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | 1.42× | — | ||
| Q1 24 | -0.12× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADMA
| ADMA Bio Manufacturing Segment | $123.1M | 88% |
| Other | $16.0M | 12% |
ESOA
| Electricals Mechanical And General | $49.4M | 43% |
| Gas And Petroleum Transmission | $24.1M | 21% |
| Cost Plus And TM Contracts | $23.3M | 20% |
| Transferred At Point In Time | $17.9M | 16% |
